EU authorises AstraZeneca COVID-19 vaccine

Image Source : AP IMAGE EU authorises AstraZeneca COVID-19 vaccine
The European Commission on Friday granted a conditional advertising and marketing authorisation (CMA) for the COVID-19 vaccine developed by multinational pharmaceutical firm AstraZeneca. “Today, the European Commission has granted a conditional marketing authorisation (CMA) for the COVID-19 vaccine developed by AstraZeneca, the third COVID-19 vaccine authorised in the EU,” the European Commission mentioned in a press release.
The fee mentioned that the AstraZeneca vaccine will likely be given to adults aged 18 years and older for stopping COVID-19.
This authorisation follows a optimistic scientific advice primarily based on a radical evaluation of the protection, effectiveness, and high quality of the vaccine by the European Medicines Agency (EMA) and is endorsed by the Member States, the fee mentioned.

The President of the European Commission, Ursula von der Leyen, mentioned: “Securing safe vaccines for Europeans is our utmost priority. With the AstraZeneca vaccine now authorized, 400 million additional doses will be available in Europe. I expect the company to deliver these doses as agreed so that Europeans can be vaccinated as soon as possible. We will continue doing all we can to secure more vaccines for Europeans, our neighbors, and our partners worldwide.”
Stella Kyriakides, Commissioner for Health and Food Safety, mentioned: “The European Medicines Agency’s authorisation today is another step towards delivering on this promise. The Commission continues to work around the clock to secure more vaccines for Europe and our international partners. We are leaving no stone unturned in our fight against this pandemic.”
According to EMA, a lot of the individuals within the research had been between 18 and 55 years previous. There aren’t but sufficient ends in older individuals (over 55 years previous) to offer a determine for the way effectively the vaccine will work on this group. 

Latest World News